NCT05895383View on ClinicalTrials.gov

Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy

PHASE4RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 24, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

January 30, 2025

Conditions
Procedural PainPain CatastrophizingProcedural Anxiety
Interventions
DRUG

Nitrous oxide

Nitrous oxide administered at concentrations of minimal sedation (0-50%). Participants will be able to adjust the level of gas throughout the vasectomy using a handheld remote control.

Trial Locations (1)

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER